Paolo Strati, MD; University of Texas MD Anderson Cancer Center 5Live #ASCO20
5:45
Key insights on Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).
Key insights on Prognostic impact of dose, duration, and timing of corticosteroid therapy in patients with large B-cell lymphoma treated with standard of care axicabtagene ciloleucel (Axi-cel).
Non-Hodgkin Lymphoma Similar Videos
-
Risk stratification and therapy for high-grade NHL_Kristie Blum, MD; #DDHO2021
2:27
-
Ranjana Advani, MD; Stanford University #BtC_ASCO21
15:14
Dr. Ranjana Advani shares strategies for Integrating Recently Approved Therapies for B-cell NHL Into Practice.
-
Loretta Nastoupil, MD; The University of Texas MD Anderson Cancer Center; 5Live #ASH21
6:24
Key insights from the 2021 Annual Hematology meeting in Atlanta